SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-119040
Filing Date
2024-11-14
Accepted
2024-11-14 16:34:56
Documents
1
Group Members
PARADIGM BIOCAPITAL ADVISORS GP LLCPARADIGM BIOCAPITAL INTERNATIONAL FUND LTD.SENAI ASEFAW, M.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427604d9_sc13ga.htm SC 13G/A 67754
  Complete submission text file 0001104659-24-119040.txt   69450
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91849 | Film No.: 241463367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 646-970-2123
Paradigm Biocapital Advisors LP (Filed by) CIK: 0001855655 (see all company filings)

IRS No.: 851451055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A